鸡AFABP蛋白的分泌特性验证及其对前脂肪细胞增殖的调控作用

doi:10.3969/j.issn.1674-7968.2026.07.013

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (7531 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Adipocyte fatty acid-binding protein (AFABP), a member of the fatty acid-binding protein family, is predominantly expressed in adipocytes, macrophages, and endothelial cells. While traditionally regarded as an intracellular fatty acid transporter, mammalian AFABP has been identified as a secretory adipokine that regulates systemic metabolism via the circulatory system. However, it remains unclear whether chicken (Gallus gallus) AFABP exhibits similar secretory property and possesses extracellular functions. In this study, Western blot analysis was used to verify the secretory capacity of chicken AFABP; CCK8 and RT-qPCR assays were used to examine its effect on chicken preadipocyte proliferation. Western blot analysis showed that chicken AFABP protein was present in the culture supernatants of the transfected cells, indicating that AFABP possessed secretory property. CCK8 and RT-qPCR assays revealed that the secreted chicken AFABP promoted preadipocyte proliferation. This study provides a foundation for further investigation into the function and mechanism of chicken AFABP.

Key words： Chicken Adipocyte fatty acid-binding protein (AFABP) Secretory proteins Preadipocyte Cell proliferation

Received: 07 July 2025

ZTFLH:

S831.2

Corresponding Authors: * wangning@neau.edu.cn

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GAO Fan
	GUO Ya-Qi
	XU Hai-Dong
	MOU Fang
	WANG Ning

Cite this article:

GAO Fan,GUO Ya-Qi,XU Hai-Dong, et al. Verification of the Secretory Property of AFABP in Chickens (Gallus gallus) and Its Regulatory Effect on Preadipocyte Proliferation[J]. 农业生物技术学报, 2026, 34(7): 1506-1516.

URL:

https://journal05.magtech.org.cn/Jwk_ny/EN/10.3969/j.issn.1674-7968.2026.07.013 OR https://journal05.magtech.org.cn/Jwk_ny/EN/Y2026/V34/I7/1506

[1] 高广亮, 关天竹, 王海威, 等. 2014. A-FABP基因与肉鸡生长和体组成性状的相关分析[J]. 中国畜牧杂志, 50(15): 28-32.
(Gao G L, Guan T Z, Wang H W, et al.2014. Correlation analysis between A-FABP gene and growth and body composition traits of broiler chickens[J]. Chinese Journal of Animal Science, 50(15): 28-32.)
[2] 王启贵, 关天竹, 王守志, 等. 2011. A-FABP基因多态性与肉鸡生长和体组成性状的关联[J]. 遗传, 33(02): 153-162.
(Wang Q G, Guan T Z, Wang S Z, et al.2011. Association between chicken A-FABP gene polymorphisms and growth and body composition traits[J]. Journal of Genetics and Genomics, 33(02): 153-162.)
[3] 张庆秋, 石慧, 王宇祥, 等. 2012. 鸡前脂肪细胞中A-FABP基因表达的变化对PPARγ、perilipin和E-FABP表达的影响[J]. 畜牧兽医学报, 43(10): 1531-1538.
(Zhang Q Q, Shi H, Wang Y X, et al.2012. The effect of changes in A-FABP gene expression in chicken preadipocytes on PPARγ, perilipin, and E-FABP expression[J]. Journal of Animal Science and Veterinary Medicine, 43(10): 1531-1538.)
[4] Bosquet A, Guaita-Esteruelas S, Saavedra P, et al.2016. Exogenous FABP4 induces endoplasmic reticulum stress in HepG2 liver cells[J]. Atherosclerosis, 249: 191-199.
[5] Cao H, Sekiya M, Ertunc M E, et al.2013. Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production[J]. Cell Metabolism, 17(5): 768-778.
[6] Dadej D, Szczepanek-Parulska E, Ruchała M, et al.2022. Interplay between fatty acid binding protein 4, fetuin-A, retinol binding protein 4 and thyroid function in metabolic dysregulation[J]. Metabolites, 12(4): 300.
[7] Ertunc M E, Sikkeland J, Fenaroli F, et al.2015. Secretion of fatty acid binding protein aP2 from adipocytes through a nonclassical pathway in response to adipocyte lipase activity[J]. Journal of Lipid Research, 56(2): 423-434.
[8] Fu Y, Luo N, Lopes-Virella M F.2000. Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages[J]. Journal of Lipid Research, 41(12): 2017-2023.
[9] Furuhashi M, Fuseya T, Murata M, et al.2016. Local production of fatty acid-binding protein 4 in epicardial/perivascular fat and macrophages is linked to coronary atherosclerosis[J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 36(5): 825-834.
[10] Furuhashi M, Saitoh S, Shimamoto K, et al.2014. Fatty acid-binding protein 4 (FABP4): Pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases[J]. Clinical Medicine Insights. Cardiology, 8(Suppl 3): 23-33.
[11] Furuhashi M.2019. Fatty acid-binding protein 4 in cardiovascular and metabolic diseases[J]. Journal of Atherosclerosis and Thrombosis, 26(3): 216-232.
[12] Girona J, Rosales R, Plana N, et al.2013. FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway[J]. PLOS ONE, 8(11): e81914.
[13] Kazemi M R, McDonald C M, Shigenaga J K, et al.2005. Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists[J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 25(6): 1220-1224.
[14] Lee M Y, Li H, Xiao Y, et al.2011. Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells[J]. British Journal of Pharmacology, 162(7): 1564-1576.
[15] Lee C, Lui D T W, Lam K S L, et al.2021. Adipocyte fatty acid-binding protein, cardiovascular diseases and mortality[J]. Frontiers in Immunology, 12: 589206.
[16] Leveque C, Marsaud V, Renoir J, et al.2007. Alternative cyclin D1 forms a and b have different biological functions in the cell cycle of B lymphocytes[J]. Experimental Cell Research, 313(12): 2719-2729.
[17] Li B, Hao J, Zeng J, Sauter E R, et al.2020, SnapShot: FABP functions[J]. Cell. 182(4): 1066-1066.e1.
[18] Li H, Wu X, Xu A, et al.2021. A-FABP in metabolic diseases and the therapeutic implications: An update[J]. International Journal of Molecular Sciences, 22(17): 9386.
[19] Llaverias G, Noe V, Penuelas S, et al.2004. Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages[J]. Biochemical and Biophysical Research Communications, 318(1): 265-274.
[20] Mita T, Furuhashi M, Hiramitsu S, et al.2015. FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms[J]. Obesity (Silver Spring), 23(2): 359-367.
[21] Shi H, Wang Q, Zhang Q, et al.2010. Tissue expression characterization of chicken adipocyte fatty acid-binding protein and its expression difference between fat and lean birds in abdominal fat tissue[J]. Poultry Science, 89(2):197-202.
[22] Smathers R L, Petersen D R.2011. The human fatty acid-binding protein family: Evolutionary divergences and functions[J]. Human Genomics, 5(3): 170-191.
[23] Trojnar M, Patro-Malysza J, Kimber-Trojnar Z, et al.2019. Associations between fatty acid-binding protein 4(-) A proinflammatory adipokine and insulin resistance, gestational and type 2 diabetes mellitus[J]. Cells, 8(3): 227.
[24] Villeneuve J, Bassaganyas L, Lepreux S, et al.2018. Unconventional secretion of FABP4 by endosomes and secretory lysosomes[J]. The Journal of Cell Biology, 217(2): 649-665.
[25] Zhang X, Tu W, Wang H, et al.2018. Circulating serum fatty acid-binding protein 4 levels predict the development of diabetic retinopathy in type 2 diabetic patients[J]. American Journal of Ophthalmology, 187: 71-79.
[26] Zhang Y, Zhang R, Li C, et al.2025. Exploring the causal association between fatty acid-binding proteins and anaphylactic shock due to adverse reactions to medications: A two-sample Mendelian randomization study[J]. Medicine (Baltimore), 104(18): e42171.